Structure-Affinity Relationships and Structure-Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A3 Receptor Antagonists

被引:24
|
作者
Xia, Lizi [1 ]
Burger, Wessel A. C. [1 ]
van Veldhoven, Jacobus P. D. [1 ]
Kuiper, Boaz J. [1 ]
van Duijl, Tirsa T. [1 ]
Lenselink, Eelke B. [1 ]
Paasman, Ellen [1 ]
Heitman, Laura H. [1 ]
IJzerman, Adriaan P. [1 ]
机构
[1] Leiden Univ, Leiden Acad Ctr Drug Res, Div Med Chem, NL-2300 RA Leiden, Netherlands
关键词
PROTEIN-COUPLED RECEPTOR; TARGET RESIDENCE TIME; MEDICINAL CHEMISTRY; CLICK CHEMISTRY; LIGAND; BINDING; RADIOLIGAND; THERMODYNAMICS; GPCRDB;
D O I
10.1021/acs.jmedchem.7b00950
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We expanded on a series of pyrido[2,1-f]purine-2,4-clione derivatives as human adenosine A(3) receptor (hA(3)R) antagonists to determine their kinetic profiles and affinities. Many compounds showed high affinities and a diverse range of kinetic profiles. We found hA(3)R antagonists with very short residence time (RT) at the receptor (2.2 min for 5) and much longer RTs (e.g., 376 min for 27 or 391 min for 31). Two representative antagonists (5 and 27) were tested in [S-35]GTP gamma S binding assays, and their RTs appeared correlated to their (in)surmountable antagonism. From a k(on)-k(off)-K-D kinetic map, we divided the antagonists into three subgroups, providing a possible direction for the further development of hA(3)R antagonists. Additionally, we performed a computational modeling study that sheds light on the crucial receptor interactions, dictating the compounds' binding kinetics. Knowledge of target binding kinetics appears useful for developing and triaging new hA(3)R antagonists in the early phase of drug discovery.
引用
收藏
页码:7555 / 7568
页数:14
相关论文
共 47 条
  • [11] Structure-Affinity Relationships and Structure-Kinetic Relationships of 1,2-Diarylimidazol-4-carboxamide Derivatives as Human Cannabinoid 1 Receptor Antagonists
    Xia, Lizi
    de Vries, Henk
    Lenselink, Eelke B.
    Louvel, Julien
    Waring, Michael J.
    Cheng, Leifeng
    Pahlen, Sara
    Petersson, Maria J.
    Schell, Peter
    Olsson, Roine I.
    Heitman, Laura H.
    Sheppard, Robert J.
    IJzerman, Adriaan P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (23) : 9545 - 9564
  • [12] When structure-affinity relationships meet structure-kinetics relationships: 3-((Inden-1-yl)amino)-1-isopropyl-cyclopentane-1-carboxamides as CCR2 antagonists
    Vilums, Maris
    Zweemer, Annelien J. M.
    Barmare, Farhana
    van der Gracht, Anouk M. F.
    Bleeker, Dave C. T.
    Yu, Zhiyi
    de Vries, Henk
    Gross, Raymond
    Clemens, Jeremy
    Krenitsky, Paul
    Brussee, Johannes
    Stamos, Dean
    Saunders, John
    Heitman, Laura H.
    IJerman, Adriaan P.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 93 : 121 - 134
  • [13] Synthesis, structure-affinity relationships, and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists
    Lenzi, Ombretta
    Colotta, Vittoria
    Catarzi, Daniela
    Varano, Flavia
    Squarcialupi, Lucia
    Filacchioni, Guido
    Varani, Katia
    Vincenzi, Fabrizio
    Borea, Pier Andrea
    Dal Ben, Diego
    Lambertucci, Catia
    Cristalli, Gloria
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (12) : 3757 - 3768
  • [14] Structure-activity relationships of thiazole and thiadiazole derivatives as potent and selective human adenosine A3 receptor antagonists.
    Kim, YC
    Jung, KY
    Kim, SK
    Gao, ZG
    Gross, AS
    Melman, N
    Jacobson, KA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U53 - U53
  • [15] Structure-activity relationship studies of a new series of imidazo[2,1-f] purinones as potent and selective A3 adenosine receptor antagonists
    Baraldi, Pier Giovanni
    Preti, Delia
    Tabrizi, Mojgan Aghazadeh
    Romagnoli, Romeo
    Saponaro, Giulia
    Baraldi, Stefania
    Botta, Maurizio
    Bernardini, Cesare
    Tafi, Andrea
    Tuccinardi, Tiziano
    Martinelli, Adriano
    Varani, Katia
    Borea, Pier Andrea
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (24) : 10281 - 10294
  • [16] 1,2,4-Triazolo[1,5-a]quinoxaline derivatives and their simplified analogues as adenosine A3 receptor antagonists. Synthesis, structure-affinity relationships and molecular modeling studies
    Catarzi, Daniela
    Varano, Flavia
    Poli, Daniela
    Squarcialupi, Lucia
    Betti, Marco
    Trincavelli, Letizia
    Martini, Claudia
    Dal Ben, Diego
    Thomas, Ajiroghene
    Volpini, Rosaria
    Colotta, Vittoria
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (01) : 9 - 21
  • [17] Synthesis and structure-activity relationships of thieno[2,3-d]pyrimidine-2,4-dione derivatives as potent GnRH receptor antagonists
    Guo, ZQ
    Chen, YS
    Wu, DP
    Zhu, YF
    Struthers, RS
    Saunders, J
    Me, Q
    Chen, C
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (20) : 3617 - 3622
  • [18] Structure-activity relationships and molecular modeling of 3,5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists
    Li, AH
    Moro, S
    Melman, N
    Ji, XD
    Jacobson, KA
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (17) : 3186 - 3201
  • [19] Pyrazolo[1,5-c]quinazoline derivatives and their simplified analogues as adenosine receptor antagonists: Synthesis, structure-affinity relationships and molecular modeling studies
    Catarzi, Daniela
    Colotta, Vittoria
    Varano, Flavia
    Poli, Daniela
    Squarcialupi, Lucia
    Filacchioni, Guido
    Varani, Katia
    Vincenzi, Fabrizio
    Borea, Pier Andrea
    Dal Ben, Diego
    Lambertucci, Catia
    Cristalli, Gloria
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (01) : 283 - 294
  • [20] Structure activity relationship of 2-arylalkynyl-adenine derivatives as human A3 adenosine receptor antagonists
    Yu, Jinha
    Mannes, Philip
    Jung, Young-Hwan
    Ciancetta, Antonella
    Bitant, Amelia
    Lieberman, David I.
    Khaznadar, Sami
    Auchampach, John A.
    Gao, Zhan-Guo
    Jacobson, Kenneth A.
    MEDCHEMCOMM, 2018, 9 (11) : 1920 - 1932